SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001829126-21-011803
Filing Date
2021-10-12
Accepted
2021-10-12 07:05:29
Documents
13
Period of Report
2021-10-12
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K inspyrtherapeutics_8k.htm   iXBRL 8-K 22445
2 EXHIBIT 99.01 inspyrtherapeutics_ex99-01.htm EX-99.01 9874
  Complete submission text file 0001829126-21-011803.txt   202409

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE nspxd-20211012.xsd EX-101.SCH 3028
4 XBRL LABEL FILE nspxd-20211012_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE nspxd-20211012_pre.xml EX-101.PRE 22360
6 EXTRACTED XBRL INSTANCE DOCUMENT inspyrtherapeutics_8k_htm.xml XML 3293
Mailing Address 2629 TOWNSGATE RD, SUITE 215 WESTLAKE VILLAGE CA 91361
Business Address 2629 TOWNSGATE RD, SUITE 215 WESTLAKE VILLAGE CA 91361 (210) 479-8112
Inspyr Therapeutics, Inc. (Filer) CIK: 0001421204 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55331 | Film No.: 211316863
SIC: 2834 Pharmaceutical Preparations